The use of antithymocyte globulin in myasthenia gravis

Barnes, A.D.

Postgraduate Medical Journal 52(5 Suppl): 110-111

1976


ISSN/ISBN: 0032-5473
PMID: 1087016
Document Number: 98358
Antithymocyte globulin (ATG) has been used to treat three female patients with myastenia gravis. No other immunosuppressive agent was used. All three cases responded favourably to ATG therapy. This suggest that further work should be undertaken in this field though the condition itself is extremely variable and this study was not controlled.

Document emailed within 1 workday
Secure & encrypted payments